(Q47989318)

7 February 2018

title

Influenza virosomes as an efficient system for adjuvanted vaccine delivery. (English)

1 reference

7 February 2018

author name string

Reinhard Glück

series ordinal

1

1 reference

7 February 2018

Christian Moser

series ordinal

2

1 reference

7 February 2018

Ian C Metcalfe

series ordinal

3

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

7 February 2018

Expert Opinion on Biological Therapy

published in

1 reference

7 February 2018

volume

4

1 reference

7 February 2018

issue

7

1 reference

7 February 2018

page(s)

1139-1145

1 reference

7 February 2018

Immunological concepts of vaccine adjuvant activity

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Recent developments in adjuvants for vaccines against infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Virosomal adjuvanted antigen delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Virosomes in vaccine development: induction of cytotoxic T lymphocyte activity with virosome-encapsulated protein antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Immunostimulating reconstituted influenza virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Coiled coils in both intracellular vesicle and viral membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Structure of influenza haemagglutinin at the pH of membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Virus-cell and cell-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Fusion of reconstituted influenza virus envelopes with liposomes mediated by streptavidin/biotin interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Architecture of the influenza hemagglutinin membrane fusion site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Leash in the groove mechanism of membrane fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Early steps of the conformational change of influenza virus hemagglutinin to a fusion active state: stability and energetics of the hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

The pathogenesis of influenza in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Virus-like particles as immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Estimated persistence of anti-HAV antibodies after single dose and booster hepatitis A vaccination (0-6 schedule).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Delivery to cancer cells of antisense L-myc oligonucleotides incorporated in fusogenic, cationic-lipid-reconstituted influenza-virus envelopes (cationic virosomes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Progress toward a malaria vaccine: efficient induction of protective anti-malaria immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Induction of parasite growth-inhibitory antibodies by a virosomal formulation of a peptidomimetic of loop I from domain III of Plasmodium falciparum apical membrane antigen 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.7.1139

10.1517/14712598.4.7.1139

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

15268680

1 reference

7 February 2018